18 November 2019
Ingenion Medical Limited appoints new CEO, Edward Cappabianca. Mr. Cappabianca is an experienced Managing Director & Investment Banker with a demonstrated history of the biotechnology industry. He graduated the University of Virginia in 1987 obtaining his BA in Chemistry/Biochemistry. He eventually went on to obtain is MBA in 1991 from the Wharton School of Finance. Mr. Cappabianca has served as the CEO of two early-stage life science companies. In addition, he has raised over $2 Billion USD in a range of financings from private & public equity to private debt and grant funding. Through his education and experience, Mr. Cappabianca has strong business development professional skills in Medical Devices, Venture Capital, Biotechnology, IPO, and Mergers & Acquisitions.